loader

cse:dtc

LATEST ARTICLES
Life Science Investing

Defence Therapeutics Completes Fully Subscribed Debenture Units Financing of $2,000,000

Life Science Investing

Defence Therapeutics Engages Dr. Amie Phinney as Strategy & Business Advisor to Guide Next Phase of Growth

Life Science Investing

Defence Therapeutics Announces Debenture Units Financing

life science investing

Defence's Novel Accum-mRNA Vaccine Now Administered for Testing on Cancer

life science investing

RETRANSMISSION: Defence Breakthrough: Successfully Engineered Accum-mRNA Vaccine Creating a New Vaccine Platform. The in vivo Accum-mRNA Cancer Vaccine Program Begins

life science investing

Defence Breakthrough: Successfully Engineered Accum-mRNA Vaccine Creating a New Vaccine Platform. The in vivo Accum-mRNA Cancer Vaccine Program Begins

life science investing

Defence to Complete a Final Pre-Clinical Study Prior to IND Filings for the AccuTOX Phase I Cancer Trial at the City of Hope National Medical Center and Beckman Research Institute

life science investing

Defence Therapeutics Announces Exercise of Warrants for Gross Proceeds of over $5 Million

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES